Literature DB >> 24956964

Time to do more: addressing clinical inertia in the management of type 2 diabetes mellitus.

W D Strain1, X Cos2, M Hirst3, S Vencio4, V Mohan5, Z Vokó6, D Yabe7, M Blüher8, P M Paldánius9.   

Abstract

AIMS: Clinical inertia, the tendency to maintain current treatment strategies despite results demanding escalation, is thought to substantially contribute to the disconnect between clinical aspirations for patients with diabetes and targets achieved. We wished to explore potential causes of clinical inertia among physicians and people with diabetes.
METHODS: A 20-min online survey of 652 adults with diabetes and 337 treating physicians in six countries explored opinions relating to clinical inertia from both perspectives, in order to correlate perceptions and expectations relating to diagnosis, treatment, diabetes complications and therapeutic escalation.
RESULTS: Physicians had low expectations for their patients, despite the belief that the importance of good glycaemic control through lifestyle and pharmacological interventions had been adequately conveyed. Conversely, people with diabetes had, at best, a rudimentary understanding of the risks of complications and the importance of good control; indeed, only a small proportion believed lifestyle changes were important and the majority did not intend to comply.
CONCLUSIONS: The principal findings of this survey suggest that impairments in communication are at the heart of clinical inertia. This manuscript lays out four key principles that we believe are achievable in all environments and can improve the lives of people with diabetes.
Copyright © 2014 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  Clinical inertia; Hypoglycaemia; Type 2 diabetes

Mesh:

Year:  2014        PMID: 24956964     DOI: 10.1016/j.diabres.2014.05.005

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  31 in total

Review 1.  Clinical and Psychosocial Factors Influencing Retinal Screening Uptake Among Young Adults with Type 2 Diabetes.

Authors:  A J Lake; G Rees; J Speight
Journal:  Curr Diab Rep       Date:  2018-05-24       Impact factor: 4.810

Review 2.  New approaches to providing individualized diabetes care in the 21st century.

Authors:  Priscilla W Powell; Sarah D Corathers; Jennifer Raymond; Randi Streisand
Journal:  Curr Diabetes Rev       Date:  2015

3.  Patients' Future Expectations for Diabetes and Hypertension Treatments: "Through the Diet… I Think This is Going to Go Away."

Authors:  Paige C Fairchild; Aviva G Nathan; Michael Quinn; Elbert S Huang; Neda Laiteerapong
Journal:  J Gen Intern Med       Date:  2016-10-11       Impact factor: 5.128

4.  Therapeutic Inertia: Still a Long Way to Go That Cannot Be Postponed.

Authors:  Manel Mata-Cases; Josep Franch-Nadal; Mònica Gratacòs; Dídac Mauricio
Journal:  Diabetes Spectr       Date:  2020-02

5.  Race, Genomics and Chronic Disease: What Patients with African Ancestry Have to Say.

Authors:  Carol R Horowitz; Kadija Ferryman; Rennie Negron; Tatiana Sabin; Mayra Rodriguez; Randi F Zinberg; Erwin Böttinger; Mimsie Robinson
Journal:  J Health Care Poor Underserved       Date:  2017

Review 6.  AFREZZA® (insulin human) Inhalation Powder: A Review in Diabetes Mellitus.

Authors:  Esther S Kim; Greg L Plosker
Journal:  Drugs       Date:  2015-09       Impact factor: 9.546

7.  Patients With Type 2 Diabetes Are Willing to Do More to Overcome Therapeutic Inertia: Results From a Double-Blind Survey.

Authors:  Steven V Edelman; Richard Wood; Michelle Roberts; Jay H Shubrook
Journal:  Clin Diabetes       Date:  2020-07

8.  Is therapeutic inertia present in hyperglycaemia, hypertension and hypercholesterolaemia management among adults with type 2 diabetes in three health clinics in Malaysia? a retrospective cohort study.

Authors:  Boon-How Chew; Husni Hussain; Ziti Akthar Supian
Journal:  BMC Fam Pract       Date:  2021-06-11       Impact factor: 2.497

9.  Clinical Considerations for Use of Initial Combination Therapy in Type 2 Diabetes.

Authors:  Avivit Cahn; William T Cefalu
Journal:  Diabetes Care       Date:  2016-08       Impact factor: 19.112

10.  Proportion of Brazilian diabetes patients that achieve treatment goals: implications for better quality of care.

Authors:  Deise Regina Baptista; Rubia Daniela Thieme; Walleri Christini Torelli Reis; Roberto Pontarolo; Cassyano Januário Correr
Journal:  Diabetol Metab Syndr       Date:  2015-12-14       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.